Michael Anthony Cammalleri is a Canadian former professional ice hockey player who played 15 seasons in the National Hockey League (NHL) for five different teams. He was selected in the second round, 49th overall, by the Los Angeles Kings at the 2001 NHL Entry Draft.
Representing Canada internationally on four occasions, Cammalleri won bronze and silver medals at the 2001 and 2002 World Junior Championships respectively. He was named the tournament’s best forward in 2002. He won a gold medal at the 2007 Men’s World Ice Hockey Championships. An all-star in college and the American Hockey League, Cammalleri played in the “Cold War”, an outdoor game that set a then world attendance record in 2001. He has also been recognized for his involvement in charitable efforts supporting children and the military.
Cammalleri now expresses in BioSteel and CBD, ‘It was a natural evolution for us’
New Horizons
It should be noted that for some time, the former NHL star, Cammalleri, watched players use oxycodone, Vicodin, Ambien, alcohol and more to deal with pain control, stress and anxiety.
When a back injury began to bother him during the 2017–18 season, Cammalleri wanted a healthier way to relieve pain. That led him to try Cannabidiol or CBD, the non-psychoactive cannabis extract, for the first time in his life.
Now that Cammalleri’s game days are over, the 37-year-old serves as co-CEO of BioSteel with Celenza and is a daily CBD user
BioSteel Sports Nutrition Inc., the company that Cammalleri founded in 2005 with John Celenza, a sports and nutrition executive, recently announced that Canadian cannabis company Canopy Growth is buying a 72 percent majority stake in BioSteel. BioSteel products were originally created by Matt Nichol, a former strength and conditioning coach at the Toronto Maple Leafs, after the NHL announcement in 2005 about the new drug testing regulations.
He says that although the stigma of using CBD in the NHL has dissipated, he knows that it still persists in the general public.
Source: Brianne Spiker | TSN
No comments:
Post a Comment